Kiwi,
I don’t see you spreading FUD and I fully support your adding to your position at these levels.
IMO, AMRN is in a downward spiral due to its own news vacuum (awaiting EU decisions, Mitigate…), while generics and Covid policies effect US revenues, multiplied by overall small cap biotech weakness in a rising rate environment.
My background and training has always been fundamental, but I’ve learned many a lesson that technicals do have a voice. I enjoy reading FFS opinions on AMRN.
For what it’s worth, I’ve found that the technician at ISI has been spot on at the macro level. He’s been saying that our right head and shoulder break will take us to 3800 and maybe 3600 (worst case) on the SP500.
Hopefully AMRN has already been scalped enough, if he is correct on the macro?
As previously stated, I’m an AMRN bull with a share count in the 100s of thousands.
Best,
x BLK BK
Market Data 
Markets 
AI
